Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Cancer Immunology, Immunotherapy : CII|July 20, 2026
Therapeutic targeting of CD47 using a tri-specific NK cell engager to inhibit multiple myelomaRatchaneewan Sumankan, Prin Sungwan, Natthanich Boonsatit, et al.
Oncology Research|September 8, 2025
Emerging HER2 Targeting Immunotherapy for CholangiocarcinomaPrin Sungwan, Jutatip Panaampon, Ratchaneewan Sumankan, et al.
International Immunopharmacology|July 5, 2024
Trastuzumab, a monoclonal anti-HER2 antibody modulates cytotoxicity against cholangiocarcinoma via multiple mechanismsJutatip Panaampon, Prin Sungwan, Sawako Fujikawa, et al.
Anticancer Research|February 29, 2024
Novel Midkine Inhibitor Induces Cell Cycle Arrest and Apoptosis in Multiple MyelomaKodcharat Cheevapruk, Mikinori Ueno, Prin Sungwan, et al.
In Vivo (Athens, Greece)|August 26, 2024
Anti-Tumor and Chemosensitizing Effects of the CDK Inhibitor Dinaciclib on Cholangiocarcinoma In Vitro and In VivoPrin Sungwan, Sonexai Kidoikhammouan, Unchalee Thonsri, et al.
Peerj|March 29, 2021
Bioinformatics analysis identified CDC20 as a potential drug target for cholangiocarcinomaPrin Sungwan, Worachart Lert-Itthiporn, Atit Silsirivanit, et al.
Investigational New Drugs|August 12, 2025
Anti-CD47 tri-specific killer engager enhances NK cell cytotoxicity against lung cancerChutipa Chiawpanit, Yupanun Wutti-In, Somsakul Pop Wongpalee, et al.
Human Cell|May 16, 2024
Establishment and characterization of TK-ALCL1: a novel NPM-ALK-positive anaplastic large-cell lymphoma cell linePrin Sungwan, Jutatip Panaampon, Ryusho Kariya, et al.
Pageof 1